Ryan Dodd, CEO and Founder of Intangic, explains why it makes good sense to use a captive for cyber and how they can help predict a frequency factor to influence pricing.
In this GCP Short, produced in partnership with MAXIS Global Benefits Network, we explore findings from the network's latest whitepaper on GLP-1s, often known as weight-loss drugs.
Richard is joined by Mat Robinson, Senior Managing Director and Captive Operations Leader, and Matt Gravelin, Managing Director in Consulting at Brown & Brown, to discuss how organisations can hone their captive strategy and achieve strong internal buy-in from across the group.
